Basaglar (insulin glargine) is a brand-name drug that’s used to help manage blood sugar levels in certain people. The drug comes as a liquid solution that’s injected under your skin.

Some Medicare plans may cover Basaglar, but it varies by plan. Learn which plans cover Basaglar, how to find coverage, and what you can expect to pay. Skip to main content ...

Basaglar (insulin glargine) is a brand-name subcutaneous injection that’s prescribed for managing blood sugar levels in certain people. As with other drugs, Basaglar can cause side effects, such ...

Insulin is a hormone that helps your body regulate blood sugar levels. People with diabetes may need injections of insulin to help regulate their blood sugar. ... Basaglar (Lilly) Semglee (Viatris) ...

Basaglar (insulin glargine) and Lantus (insulin glargine) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to: improve blood sugar levels in ...

The goal of the study was to evaluate change in HbA1c after initiation of biosimilar follow-on insulin (Basaglar, Eli Lilly) or reference insulin (Lantus, Sanofi) among adults with type 2 diabetes ...

Perspectives > Building the Patient-Centered Medical Home 'Just Say No' to the Medication Switches — It's time to stop letting insurers dictate what we can prescribe to our patients ...

In a separate 26-week trial of type 2 patients who have been using insulin, those on efsitora and the comparator daily insulin glargine, sold by Lilly as Basaglar and Sanofi as Lantus, both saw ...

Basaglar is a long-acting insulin that may be available through Medicare Part D. If a person’s drug plan includes Basaglar, the plan cannot charge more than $35 per month. Basaglar is a brand ...